HealthLeaders Media September 20, 2022
Laura Beerman

With few exceptions, highlights from KFF’s review reveal much parity between the programs.

In a review of 62 studies comparing original Medicare and Medicare Advantage (MA), Kaiser Family Foundation (KFF) found “few big differences…on a variety of measures.” These measures included beneficiary experience, affordability, service utilization, and quality. KFF noted that these results were based on “strong evidence or [findings that] have been replicated across multiple studies.”

The review, summarized in a KFF press release, included studies published since 2016. Among the following findings, KFF noted that “relatively few studies specifically examine … population subgroups,” including people of color, rural residents, and dual eligibles.

  1. No real difference—across all quality measures.

    It’s one thing to have parity, or differences, on...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Medicare, Medicare Advantage, Patient / Consumer, Provider, Survey / Study, Trends
Medicare’s Selection Of 15 More Drugs For Price Negotiation Puts Spotlight Back On IRA
How Many Physicians Have Opted Out of the Medicare Program? - 2
MedPAC Members Vote to Recommend Pay Hikes for Physicians and Hospitals
Opinion: Former Trump health official: Medicare should cover Wegovy — but not negotiate its price
Medicare will negotiate Novo’s GLP-1 drug price. Here’s what that means for Ozempic, Wegovy.

Share This Article